Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling
Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds wit...
Gespeichert in:
Veröffentlicht in: | Aging cell 2021-10, Vol.20 (10), p.e13480-n/a |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 10 |
container_start_page | e13480 |
container_title | Aging cell |
container_volume | 20 |
creator | Dang, Ruili Yang, Mengqi Cui, Changmeng Wang, Changshui Zhang, Wenyuan Geng, Chunmei Han, Wenxiu Jiang, Pei |
description | Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds with Mas receptor (MasR) to restrain excessive inflammatory response. Therefore, the present study aims to explore the relationship between RAS and neuroinflammation. We found that repeated lipopolysaccharide (LPS) treatment shifted the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7)/MasR axis to the deleterious side and treatment with either MasR agonist, AVE0991 (AVE) or ACE2 activator, diminazene aceturate, exhibited strong neuroprotective actions. Mechanically, activation of ACE2/Ang(1–7)/MasR axis triggered the Forkhead box class O1 (FOXO1)‐autophagy pathway and induced superoxide dismutase (SOD) and catalase (CAT), the FOXO1‐targeted antioxidant enzymes. Meanwhile, knockdown of MasR or FOXO1 in BV2 cells, or using the selective FOXO1 inhibitor, AS1842856, in animals, suppressed FOXO1 translocation and compromised the autophagic process induced by MasR activation. We further used chloroquine (CQ) to block autophagy and showed that suppressing either FOXO1 or autophagy abrogated the anti‐inflammatory action of AVE. Likewise, Ang(1–7) also induced FOXO1 signaling and autophagic flux following LPS treatment in BV2 cells. Cotreatment with AS1842856 or CQ all led to autophagic inhibition and thereby abolished Ang(1–7)‐induced remission on NLRP3 inflammasome activation caused by LPS exposure, shifting the microglial polarization from M1 to M2 phenotype. Collectively, these results firstly illustrated the mechanism of ACE2/Ang(1–7)/MasR axis in neuroinflammation, strongly indicating the involvement of FOXO1‐mediated autophagy in the neuroimmune‐modulating effects triggered by MasR activation.
The neuroimmune‐regulatory mechanism of ACE2/Ang(1–7)/MasR axis. ACE2 cleaves AngII into Ang(1–7), which than binds with MasR. The activation of MasR triggers FOXO1 translocation and induces autophagic process, thereby accelerating the clearance of NLRP3 inflammasome. |
doi_str_mv | 10.1111/acel.13480 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8520723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2582588551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4480-dca444ca3885db3a9bd5bd9b2397ad674c92e04c8a0d08210a795170ad2023303</originalsourceid><addsrcrecordid>eNp9kkFu1DAUhiMEomVgwwGQJTYFaTq240ycTaXRqAWkkbqBtfXiOBkXxw52MjRd9QhIvRFH6UnwkDIqLLCeZEvv86_fz3-SvCb4lMS1AKnMKUkZx0-SY8JyNi9yunx6OBN-lLwI4Qpjkhc4fZ4cpSyjBefkOPm5kr3eQa-dRa5GYBvtemWDtve3P6SzO-V7bRuk7M3YKkQXjwh0Qu5v7_J3ixYC8kqqrncewbUOqPe6aZQPCIbedVtoxihdoTB0nVchqIBaLb1rjAbUeadtbaBtId4fUecMeH0zedpFoHb-61ZBhUp3jaSBENAlQUE3Fkz09jJ5VoMJ6tXDPku-XJx_Xn-cby4_fFqvNnPJ4mjmlQTGmISU86wqUyjKKiuroqRpkUO1zJksqMJMcsAV5pRgyIuM5Bgqimma4nSWnE263VC2qpLK9h6M6LxuwY_CgRZ_d6zeisbtBM8ozqPELDl5EPDu26BCL1od4t8ZsMoNQdAsZwyz5ZJG9O0_6JUbfHzvnuKxeJaRSL2fqDjKELyqD2YIFvtoiH00xO9oRPjNY_sH9E8WIkAm4Ls2avyPlFitzzeT6C_DocuA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2582588551</pqid></control><display><type>article</type><title>Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Dang, Ruili ; Yang, Mengqi ; Cui, Changmeng ; Wang, Changshui ; Zhang, Wenyuan ; Geng, Chunmei ; Han, Wenxiu ; Jiang, Pei</creator><creatorcontrib>Dang, Ruili ; Yang, Mengqi ; Cui, Changmeng ; Wang, Changshui ; Zhang, Wenyuan ; Geng, Chunmei ; Han, Wenxiu ; Jiang, Pei</creatorcontrib><description>Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds with Mas receptor (MasR) to restrain excessive inflammatory response. Therefore, the present study aims to explore the relationship between RAS and neuroinflammation. We found that repeated lipopolysaccharide (LPS) treatment shifted the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7)/MasR axis to the deleterious side and treatment with either MasR agonist, AVE0991 (AVE) or ACE2 activator, diminazene aceturate, exhibited strong neuroprotective actions. Mechanically, activation of ACE2/Ang(1–7)/MasR axis triggered the Forkhead box class O1 (FOXO1)‐autophagy pathway and induced superoxide dismutase (SOD) and catalase (CAT), the FOXO1‐targeted antioxidant enzymes. Meanwhile, knockdown of MasR or FOXO1 in BV2 cells, or using the selective FOXO1 inhibitor, AS1842856, in animals, suppressed FOXO1 translocation and compromised the autophagic process induced by MasR activation. We further used chloroquine (CQ) to block autophagy and showed that suppressing either FOXO1 or autophagy abrogated the anti‐inflammatory action of AVE. Likewise, Ang(1–7) also induced FOXO1 signaling and autophagic flux following LPS treatment in BV2 cells. Cotreatment with AS1842856 or CQ all led to autophagic inhibition and thereby abolished Ang(1–7)‐induced remission on NLRP3 inflammasome activation caused by LPS exposure, shifting the microglial polarization from M1 to M2 phenotype. Collectively, these results firstly illustrated the mechanism of ACE2/Ang(1–7)/MasR axis in neuroinflammation, strongly indicating the involvement of FOXO1‐mediated autophagy in the neuroimmune‐modulating effects triggered by MasR activation.
The neuroimmune‐regulatory mechanism of ACE2/Ang(1–7)/MasR axis. ACE2 cleaves AngII into Ang(1–7), which than binds with MasR. The activation of MasR triggers FOXO1 translocation and induces autophagic process, thereby accelerating the clearance of NLRP3 inflammasome.</description><identifier>ISSN: 1474-9718</identifier><identifier>EISSN: 1474-9726</identifier><identifier>DOI: 10.1111/acel.13480</identifier><identifier>PMID: 34529881</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>ACE2 ; Aging ; Alzheimer's disease ; Angiotensin AT1 receptors ; Angiotensin I - pharmacology ; Angiotensin I - therapeutic use ; Angiotensin II ; Angiotensin-converting enzyme 2 ; Angiotensin-Converting Enzyme 2 - pharmacology ; Angiotensin-Converting Enzyme 2 - therapeutic use ; Animals ; Antioxidants ; Autophagy ; Autophagy - drug effects ; Biomarkers ; Brain research ; Catalase ; Chloroquine ; Cytokines ; Enzymes ; Forkhead protein ; FOXO1 ; FOXO1 protein ; Genotype & phenotype ; Humans ; Immune system ; Inflammasomes ; Inflammation ; Lipopolysaccharides ; Mice ; Microglia ; Microglia - drug effects ; neuroinflammation ; Neuroinflammatory Diseases - drug therapy ; Neuroinflammatory Diseases - genetics ; Neuroprotection ; Original Paper ; Original Papers ; Peptide Fragments - pharmacology ; Peptide Fragments - therapeutic use ; Phagocytosis ; Phenotypes ; Polarization ; Protein expression ; Proteins ; Remission ; Renin ; renin‐angiotensin system ; Signal Transduction ; Superoxide dismutase ; Transfection ; Tumor necrosis factor-TNF</subject><ispartof>Aging cell, 2021-10, Vol.20 (10), p.e13480-n/a</ispartof><rights>2021 The Authors. published by Anatomical Society and John Wiley & Sons Ltd.</rights><rights>2021 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4480-dca444ca3885db3a9bd5bd9b2397ad674c92e04c8a0d08210a795170ad2023303</citedby><cites>FETCH-LOGICAL-c4480-dca444ca3885db3a9bd5bd9b2397ad674c92e04c8a0d08210a795170ad2023303</cites><orcidid>0000-0002-8360-7427</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520723/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520723/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34529881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dang, Ruili</creatorcontrib><creatorcontrib>Yang, Mengqi</creatorcontrib><creatorcontrib>Cui, Changmeng</creatorcontrib><creatorcontrib>Wang, Changshui</creatorcontrib><creatorcontrib>Zhang, Wenyuan</creatorcontrib><creatorcontrib>Geng, Chunmei</creatorcontrib><creatorcontrib>Han, Wenxiu</creatorcontrib><creatorcontrib>Jiang, Pei</creatorcontrib><title>Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling</title><title>Aging cell</title><addtitle>Aging Cell</addtitle><description>Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds with Mas receptor (MasR) to restrain excessive inflammatory response. Therefore, the present study aims to explore the relationship between RAS and neuroinflammation. We found that repeated lipopolysaccharide (LPS) treatment shifted the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7)/MasR axis to the deleterious side and treatment with either MasR agonist, AVE0991 (AVE) or ACE2 activator, diminazene aceturate, exhibited strong neuroprotective actions. Mechanically, activation of ACE2/Ang(1–7)/MasR axis triggered the Forkhead box class O1 (FOXO1)‐autophagy pathway and induced superoxide dismutase (SOD) and catalase (CAT), the FOXO1‐targeted antioxidant enzymes. Meanwhile, knockdown of MasR or FOXO1 in BV2 cells, or using the selective FOXO1 inhibitor, AS1842856, in animals, suppressed FOXO1 translocation and compromised the autophagic process induced by MasR activation. We further used chloroquine (CQ) to block autophagy and showed that suppressing either FOXO1 or autophagy abrogated the anti‐inflammatory action of AVE. Likewise, Ang(1–7) also induced FOXO1 signaling and autophagic flux following LPS treatment in BV2 cells. Cotreatment with AS1842856 or CQ all led to autophagic inhibition and thereby abolished Ang(1–7)‐induced remission on NLRP3 inflammasome activation caused by LPS exposure, shifting the microglial polarization from M1 to M2 phenotype. Collectively, these results firstly illustrated the mechanism of ACE2/Ang(1–7)/MasR axis in neuroinflammation, strongly indicating the involvement of FOXO1‐mediated autophagy in the neuroimmune‐modulating effects triggered by MasR activation.
The neuroimmune‐regulatory mechanism of ACE2/Ang(1–7)/MasR axis. ACE2 cleaves AngII into Ang(1–7), which than binds with MasR. The activation of MasR triggers FOXO1 translocation and induces autophagic process, thereby accelerating the clearance of NLRP3 inflammasome.</description><subject>ACE2</subject><subject>Aging</subject><subject>Alzheimer's disease</subject><subject>Angiotensin AT1 receptors</subject><subject>Angiotensin I - pharmacology</subject><subject>Angiotensin I - therapeutic use</subject><subject>Angiotensin II</subject><subject>Angiotensin-converting enzyme 2</subject><subject>Angiotensin-Converting Enzyme 2 - pharmacology</subject><subject>Angiotensin-Converting Enzyme 2 - therapeutic use</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Autophagy</subject><subject>Autophagy - drug effects</subject><subject>Biomarkers</subject><subject>Brain research</subject><subject>Catalase</subject><subject>Chloroquine</subject><subject>Cytokines</subject><subject>Enzymes</subject><subject>Forkhead protein</subject><subject>FOXO1</subject><subject>FOXO1 protein</subject><subject>Genotype & phenotype</subject><subject>Humans</subject><subject>Immune system</subject><subject>Inflammasomes</subject><subject>Inflammation</subject><subject>Lipopolysaccharides</subject><subject>Mice</subject><subject>Microglia</subject><subject>Microglia - drug effects</subject><subject>neuroinflammation</subject><subject>Neuroinflammatory Diseases - drug therapy</subject><subject>Neuroinflammatory Diseases - genetics</subject><subject>Neuroprotection</subject><subject>Original Paper</subject><subject>Original Papers</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peptide Fragments - therapeutic use</subject><subject>Phagocytosis</subject><subject>Phenotypes</subject><subject>Polarization</subject><subject>Protein expression</subject><subject>Proteins</subject><subject>Remission</subject><subject>Renin</subject><subject>renin‐angiotensin system</subject><subject>Signal Transduction</subject><subject>Superoxide dismutase</subject><subject>Transfection</subject><subject>Tumor necrosis factor-TNF</subject><issn>1474-9718</issn><issn>1474-9726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp9kkFu1DAUhiMEomVgwwGQJTYFaTq240ycTaXRqAWkkbqBtfXiOBkXxw52MjRd9QhIvRFH6UnwkDIqLLCeZEvv86_fz3-SvCb4lMS1AKnMKUkZx0-SY8JyNi9yunx6OBN-lLwI4Qpjkhc4fZ4cpSyjBefkOPm5kr3eQa-dRa5GYBvtemWDtve3P6SzO-V7bRuk7M3YKkQXjwh0Qu5v7_J3ixYC8kqqrncewbUOqPe6aZQPCIbedVtoxihdoTB0nVchqIBaLb1rjAbUeadtbaBtId4fUecMeH0zedpFoHb-61ZBhUp3jaSBENAlQUE3Fkz09jJ5VoMJ6tXDPku-XJx_Xn-cby4_fFqvNnPJ4mjmlQTGmISU86wqUyjKKiuroqRpkUO1zJksqMJMcsAV5pRgyIuM5Bgqimma4nSWnE263VC2qpLK9h6M6LxuwY_CgRZ_d6zeisbtBM8ozqPELDl5EPDu26BCL1od4t8ZsMoNQdAsZwyz5ZJG9O0_6JUbfHzvnuKxeJaRSL2fqDjKELyqD2YIFvtoiH00xO9oRPjNY_sH9E8WIkAm4Ls2avyPlFitzzeT6C_DocuA</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Dang, Ruili</creator><creator>Yang, Mengqi</creator><creator>Cui, Changmeng</creator><creator>Wang, Changshui</creator><creator>Zhang, Wenyuan</creator><creator>Geng, Chunmei</creator><creator>Han, Wenxiu</creator><creator>Jiang, Pei</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8360-7427</orcidid></search><sort><creationdate>202110</creationdate><title>Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling</title><author>Dang, Ruili ; Yang, Mengqi ; Cui, Changmeng ; Wang, Changshui ; Zhang, Wenyuan ; Geng, Chunmei ; Han, Wenxiu ; Jiang, Pei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4480-dca444ca3885db3a9bd5bd9b2397ad674c92e04c8a0d08210a795170ad2023303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>ACE2</topic><topic>Aging</topic><topic>Alzheimer's disease</topic><topic>Angiotensin AT1 receptors</topic><topic>Angiotensin I - pharmacology</topic><topic>Angiotensin I - therapeutic use</topic><topic>Angiotensin II</topic><topic>Angiotensin-converting enzyme 2</topic><topic>Angiotensin-Converting Enzyme 2 - pharmacology</topic><topic>Angiotensin-Converting Enzyme 2 - therapeutic use</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Autophagy</topic><topic>Autophagy - drug effects</topic><topic>Biomarkers</topic><topic>Brain research</topic><topic>Catalase</topic><topic>Chloroquine</topic><topic>Cytokines</topic><topic>Enzymes</topic><topic>Forkhead protein</topic><topic>FOXO1</topic><topic>FOXO1 protein</topic><topic>Genotype & phenotype</topic><topic>Humans</topic><topic>Immune system</topic><topic>Inflammasomes</topic><topic>Inflammation</topic><topic>Lipopolysaccharides</topic><topic>Mice</topic><topic>Microglia</topic><topic>Microglia - drug effects</topic><topic>neuroinflammation</topic><topic>Neuroinflammatory Diseases - drug therapy</topic><topic>Neuroinflammatory Diseases - genetics</topic><topic>Neuroprotection</topic><topic>Original Paper</topic><topic>Original Papers</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peptide Fragments - therapeutic use</topic><topic>Phagocytosis</topic><topic>Phenotypes</topic><topic>Polarization</topic><topic>Protein expression</topic><topic>Proteins</topic><topic>Remission</topic><topic>Renin</topic><topic>renin‐angiotensin system</topic><topic>Signal Transduction</topic><topic>Superoxide dismutase</topic><topic>Transfection</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dang, Ruili</creatorcontrib><creatorcontrib>Yang, Mengqi</creatorcontrib><creatorcontrib>Cui, Changmeng</creatorcontrib><creatorcontrib>Wang, Changshui</creatorcontrib><creatorcontrib>Zhang, Wenyuan</creatorcontrib><creatorcontrib>Geng, Chunmei</creatorcontrib><creatorcontrib>Han, Wenxiu</creatorcontrib><creatorcontrib>Jiang, Pei</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Aging cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dang, Ruili</au><au>Yang, Mengqi</au><au>Cui, Changmeng</au><au>Wang, Changshui</au><au>Zhang, Wenyuan</au><au>Geng, Chunmei</au><au>Han, Wenxiu</au><au>Jiang, Pei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling</atitle><jtitle>Aging cell</jtitle><addtitle>Aging Cell</addtitle><date>2021-10</date><risdate>2021</risdate><volume>20</volume><issue>10</issue><spage>e13480</spage><epage>n/a</epage><pages>e13480-n/a</pages><issn>1474-9718</issn><eissn>1474-9726</eissn><abstract>Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds with Mas receptor (MasR) to restrain excessive inflammatory response. Therefore, the present study aims to explore the relationship between RAS and neuroinflammation. We found that repeated lipopolysaccharide (LPS) treatment shifted the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7)/MasR axis to the deleterious side and treatment with either MasR agonist, AVE0991 (AVE) or ACE2 activator, diminazene aceturate, exhibited strong neuroprotective actions. Mechanically, activation of ACE2/Ang(1–7)/MasR axis triggered the Forkhead box class O1 (FOXO1)‐autophagy pathway and induced superoxide dismutase (SOD) and catalase (CAT), the FOXO1‐targeted antioxidant enzymes. Meanwhile, knockdown of MasR or FOXO1 in BV2 cells, or using the selective FOXO1 inhibitor, AS1842856, in animals, suppressed FOXO1 translocation and compromised the autophagic process induced by MasR activation. We further used chloroquine (CQ) to block autophagy and showed that suppressing either FOXO1 or autophagy abrogated the anti‐inflammatory action of AVE. Likewise, Ang(1–7) also induced FOXO1 signaling and autophagic flux following LPS treatment in BV2 cells. Cotreatment with AS1842856 or CQ all led to autophagic inhibition and thereby abolished Ang(1–7)‐induced remission on NLRP3 inflammasome activation caused by LPS exposure, shifting the microglial polarization from M1 to M2 phenotype. Collectively, these results firstly illustrated the mechanism of ACE2/Ang(1–7)/MasR axis in neuroinflammation, strongly indicating the involvement of FOXO1‐mediated autophagy in the neuroimmune‐modulating effects triggered by MasR activation.
The neuroimmune‐regulatory mechanism of ACE2/Ang(1–7)/MasR axis. ACE2 cleaves AngII into Ang(1–7), which than binds with MasR. The activation of MasR triggers FOXO1 translocation and induces autophagic process, thereby accelerating the clearance of NLRP3 inflammasome.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>34529881</pmid><doi>10.1111/acel.13480</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-8360-7427</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1474-9718 |
ispartof | Aging cell, 2021-10, Vol.20 (10), p.e13480-n/a |
issn | 1474-9718 1474-9726 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8520723 |
source | MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | ACE2 Aging Alzheimer's disease Angiotensin AT1 receptors Angiotensin I - pharmacology Angiotensin I - therapeutic use Angiotensin II Angiotensin-converting enzyme 2 Angiotensin-Converting Enzyme 2 - pharmacology Angiotensin-Converting Enzyme 2 - therapeutic use Animals Antioxidants Autophagy Autophagy - drug effects Biomarkers Brain research Catalase Chloroquine Cytokines Enzymes Forkhead protein FOXO1 FOXO1 protein Genotype & phenotype Humans Immune system Inflammasomes Inflammation Lipopolysaccharides Mice Microglia Microglia - drug effects neuroinflammation Neuroinflammatory Diseases - drug therapy Neuroinflammatory Diseases - genetics Neuroprotection Original Paper Original Papers Peptide Fragments - pharmacology Peptide Fragments - therapeutic use Phagocytosis Phenotypes Polarization Protein expression Proteins Remission Renin renin‐angiotensin system Signal Transduction Superoxide dismutase Transfection Tumor necrosis factor-TNF |
title | Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A35%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20angiotensin%E2%80%90converting%20enzyme%202/angiotensin%20(1%E2%80%937)/mas%20receptor%20axis%20triggers%20autophagy%20and%20suppresses%20microglia%20proinflammatory%20polarization%20via%20forkhead%20box%20class%20O1%20signaling&rft.jtitle=Aging%20cell&rft.au=Dang,%20Ruili&rft.date=2021-10&rft.volume=20&rft.issue=10&rft.spage=e13480&rft.epage=n/a&rft.pages=e13480-n/a&rft.issn=1474-9718&rft.eissn=1474-9726&rft_id=info:doi/10.1111/acel.13480&rft_dat=%3Cproquest_pubme%3E2582588551%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2582588551&rft_id=info:pmid/34529881&rfr_iscdi=true |